Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 

Click here to view
our current issue



 
 

Challenges in the Manufacture of Antibody Drug Conjugates

Antibody drug conjugates (ADCs) represent potent new weapons in the anticancer drug arsenal but their manufacture presents a series of engineering and chemistry challenges.

By Thomas Roher at Lonza Custom Manufacturing, Chemical Manufacturing (March 2010)

Keywords: manufacture, Lonza, ADC, Antibody, weapon, drug, cancer, molecule, chemotherapeutic, silver bullet, challenge, Rohrer

    View full article    |    Back to Manufacturing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | caitlin@samedanltd.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |